NCT03040622View on ClinicalTrials.gov

The Evaluation of Thrombogenicity in Patients Undergoing WATCHMAN Left Atrial Appendage Closure Trial

CompletedOBSERVATIONAL
Enrollment

35

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

October 15, 2019

Study Completion Date

December 31, 2019

Conditions
Left Atrial Appendage ClosureWATCHMAN Device Implantation
Interventions
DEVICE

WATCHMAN Left Atrial Appendage Closure

WATCHMAN Left Atrial Appendage Closure

Trial Locations (1)

22042

Inova Fairfax Hospital, Falls Church

Sponsors
All Listed Sponsors
collaborator

Boston Scientific Corporation

INDUSTRY

lead

Inova Health Care Services

OTHER